Skip to content
BIO lauds passage of PPRV reauthorization and legislation on PBM reform
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new ...
Read More
BIO tells Congress how to maintain US biotech leadership
Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate ...
Read More
Program harnesses the power of mentorship for patient organization leaders
In 2020, the Milken Institute launched the FasterCures LeadersLink Program to build capacity ...
Read More
BIO Investment Council will bring together VC and small biotechs to boost innovation
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation ...
Read More
BIO warns of risks from change to CDC’s vaccine recommendations
The Biotechnology Innovation Organization (BIO) warned that new changes in federal recommendations for ...
Read More
Using AI In patent practice: Practical and ethical issues
The use of AI tools in the workplace is on the rise. This ...
Read More
EDITORS' CHOICE
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More
LATEST NEWS
BIO's View
The hidden layer of PBMs: What a recent investigation reveals
With health care affordability a top concern for many Americans, pharmacy benefit managers (PBMs) continue to stand at the center of the debate. Working with ...
BIO's View
Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care
Americans are frustrated with the health care system for two reasons. First, it costs too much. But—second—it provides too little. While most of the dialogue ...
BIO Events
BIG Summit: Experts see signs of M&A momentum in 2026
We could be in for another big year of biotech M&A. A busy 2025, in both licensing and M&A in biopharma, saw over 4,000 deals ...
BIO Events
BIG Summit: Seeking opportunities while navigating risks of global trade
China is becoming an increasingly influential player in the global biotech market. More than a third of U.S. licensing deals this year have involved assets ...
Federal Policy
BIO Patient Advocacy Coffee Chat: Act now to be heard on CMS drug pricing
The Medicare drug price “negotiation” process has entered its third year, with some evolution but continued complexity for patients and patient organizations. This year, 15 ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
The hidden layer of PBMs: What a recent investigation reveals
With health care affordability a top concern for many Americans, pharmacy benefit managers (PBMs) continue to stand at the center ...
Read More
